SCHEMBL6603678

SCHEMBL6603678

CCC1CCCCC1OC=O

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ADH1C P00326 2/20 0.31
ADH1A P07327 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17085352 0.80
SCHEMBL10010751 0.79 CHRNB2 (0.33)
SCHEMBL3110415 0.79
SCHEMBL7207291 0.78 ALOX5 (0.37) ADH1CADH1A
SCHEMBL13515822 0.77 ADH1A (0.33) ADH1CADH1A
SCHEMBL23670187 0.76 MEN1 (0.36)
SCHEMBL14952743 0.76
SCHEMBL23670442 0.76 MEN1 (0.36)
SCHEMBL19285359 0.76 MEN1 (0.36)
SCHEMBL17580527 0.76 ALOX5 (0.34) ADH1CADH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9528042-B1 Drilling fluid additive composition and super high temperature super high density clay-free oil-in-water drilling fluid CHINA UNIVERSITY OF PETROLEUM (BEIJING) (CN) 2016-12-27 US disclosed
EP-1395251-A2 AMINEDIOLS AS AGENTS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-03-10 EP disclosed
WO-2002100818-A2 AMINEDIOLS AS AGENTS FOR THE TREATMENT OF ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-12-19 WO disclosed
EP-0925063-A4 HYPOGLYCEMIC AND HYPOLIPIDEMIC COMPOUNDS LILLY CO ELI (US) 2000-12-27 EP disclosed
EP-0925063-A1 HYPOGLYCEMIC AND HYPOLIPIDEMIC COMPOUNDS ELI LILLY AND COMPANY (US) 1999-06-30 EP disclosed
WO-1998000137-A1 HYPOGLYCEMIC AND HYPOLIPIDEMIC COMPOUNDS ELI LILLY AND COMPANY (US) 1998-01-08 WO disclosed